Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancersSimona Camorani, Laura Cerchia|Scientific Reports|2017Cited by 93
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ AptamerSimona Camorani, Antonella Zannetti|Theranostics|2017Cited by 91
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancerSimona Camorani, Laura Cerchia|Journal of Experimental & Clinical Cancer Research|2020Cited by 70
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cellsSimona Camorani, Laura Cerchia|Oncotarget|2015Cited by 67
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapiesSimona Camorani, Laura Cerchia|Journal of Experimental & Clinical Cancer Research|2024Cited by 23